Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ragavendra Baliga"'
Autor:
Lisa Kim, Brian Fowler, Courtney M. Campbell, Jeremy Slivnick, Haseeb Nawaz, Yaquta Kaka, Patrick Ruz, Ajay Vallakati, Ragavendra Baliga, Sumithira Vasu, Daniel Addison
Publikováno v:
Cardio-Oncology, Vol 7, Iss 1, Pp 1-6 (2021)
Abstract Background Gilteritinib is a novel FMS-like tyrosine kinase 3 inhibitor recently approved by the United States Food and Drug Administration in 2018 for relapsed or refractory acute myeloid leukemia. However, gilteritinib may be associated wi
Externí odkaz:
https://doaj.org/article/b4306920ee594eb89324f714cb2457be
Autor:
Sagar Sardesai, Jasmine Sukumar, Mahmoud Kassem, Marilly Palettas, Julie Stephens, Evan Morgan, Daniel Addison, Ragavendra Baliga, Daniel G. Stover, Jeffrey VanDeusen, Nicole Williams, Mathew Cherian, Maryam Lustberg, Robert Wesolowski, Bhuvaneswari Ramaswamy
Publikováno v:
Cardio-Oncology, Vol 6, Iss 1, Pp 1-9 (2020)
Abstract Background Trastuzumab-induced cardiotoxicity (TIC) can lead to early discontinuation of adjuvant therapy, however there is limited evidence on long-term survival outcomes in patients with operable human epidermal growth factor receptor 2 (H
Externí odkaz:
https://doaj.org/article/c6d7e3379144406db164240900da2ce2
Autor:
Avirup Guha, Lai Wei, Sumithira Vasu, Daniel Addison, Jonathan E Brammer, Zachary Braunstein, Aashish Katapadi, Kyle Porter, Michael Biersmith, Vedat O Yildiz, Sakima A Smith, Benjamin Buck, Devin Haddad, Richard Gumina, Basem M William, Sam Penza, Ayman Saad, Nathan Denlinger, Ajay Vallakati, Ragavendra Baliga, Raymond Benza, Philip Binkley, Mason Mocarski, Steven M Devine, Samantha Jaglowski
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Externí odkaz:
https://doaj.org/article/0549dc4da85f4345b069b254b508c05d
Autor:
Sardesai, Sagar, Sukumar, Jasmine, Kassem, Mahmoud, Marilly Palettas, Stephens, Julie, Morgan, Evan, Addison, Daniel, Ragavendra Baliga, Stover, Daniel G., VanDeusen, Jeffrey, Williams, Nicole, Cherian, Mathew, Lustberg, Maryam, Wesolowski, Robert, Bhuvaneswari Ramaswamy
Additional file 1: Supplementary Table. Baseline characteristics of patients who received trastuzumab, categorized by completion vs interruption of therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c12d70694d307f5b9514cffdb6043ec
Autor:
Saad Ullah Malik, Zachary Braunstein, Sumithira Vasu, Sam Penza, Ayman Saad, Nathan Denlinger, Marcos J.G. de Lima, Ajay Vallakati, Ragavendra Baliga, Samantha Jaglowski, Jonathan E. Brammer, Daniel Addison
Publikováno v:
Blood. 138:2918-2918
Introduction Hematopoietic stem cell transplant (HSCT) is commonly performed for the treatment of advanced hematological malignancies. Emerging data suggest non-relapse related events, including cardiac arrhythmias, increasingly limit anticancer outc
Autor:
Mohan Thanikachalam, Vijaykumar Harivanzan, Jahnavi Sunderarajan, Ragavendra Baliga, Sadagopan Thanikachalam
Publikováno v:
Circulation. 130
Background: Diabetes mellitus (DM) is a risk factor for cardiovascular morbidity and mortality. In the current study we examine the association of hyperglycemic with left ventricular hypertrophy (LVH) independent of major correlates of LVH, such as,
Autor:
Mohan Thanikachalam, Jahnavi Sunderarajan, Sadagopan Thanikachalam, Kwan Hk Chui, Kevin J Lane, Ragavendra Baliga, Hari Vanzan
Publikováno v:
Journal of the American College of Cardiology. 65:A1497
Autor:
Ragavendra Baliga, Wajih Syed, Vijayakumar Harivanzan, Jahnavi Sunderarajan, Mohan Thanikachalam, Natesa G. Pandian, Sadagopan Thanikachalam
Publikováno v:
Journal of the American College of Cardiology. 63:A1419